For those who suffer from rare diseases or physical conditions which have never come into the spotlight, help is finally coming. The umbrella company, Paragon Biosciences, has made its highest goal the identification of and treatment development for these unaddressed health issues. The company, founded by celebrated physician Jeff Aronin, is on a worldwide search for cutting-edge ideas for understanding the underlying causes of these rare diseases and all the ways they are manifested. Using the many resources Paragon has amassed since its beginning, new companies are being built to address specific needs.
Jeff Aronin’s great passion is to find ways to solve the problems which have not had the needed resources and expertise to be properly addressed. Through Paragon, world-class experts can be joined with the latest break-through science for a quicker result. Paragon provides critical assistance for the infrastructure, planning, and building of companies focusing on specific areas of need. Through this support system, a new generation of health-care leaders is rising up and being sustained.
Jeff Aronin continues to be a champion of the development of and access to new medical treatments (Gazetteday). He participates in and supports organizations all over the globe in an effort to improve education and the individual’s quality of life. The healthcare incubator he has founded in Chicago is currently assisting over 200 companies in various stages of development. Research in skin and liver diseases, diabetes and Cystic Fibrosis are just a few of the areas in which Aronin has invested.
Paragon Biosciences has the resources to bring together the expertise needed to better address the conditions which afflict so many without any effective treatment options. It is hoped that their efforts will continue to yield new applications for sufferers and stir further interest in research in the medical world. Award-winning entrepreneurs such as Jeff Aronin challenge adept physicians and other scientists to come together for the amelioration of present health care options. Future generations can look forward to the alleviation of much suffering as a result of the research companies founded under Paragon Biosciences.